These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 30243716)
1. Production and characterization of monoclonal antibody against a triple negative breast cancer cell line. Ghaderi F; Ahmadvand S; Ramezani A; Montazer M; Ghaderi A Biochem Biophys Res Commun; 2018 Oct; 505(1):181-186. PubMed ID: 30243716 [TBL] [Abstract][Full Text] [Related]
2. Production of anti-tumor human monoclonal antibodies using different approaches. Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684 [TBL] [Abstract][Full Text] [Related]
3. Production of anti-CD14 monoclonal antibody using synthetic peptide of human CD14 as immunizing antigen. Maleki LA; Shanehbandi D; Majidi J; Yusefi M; Abdolalizadeh J; Orangi M; Baradaran B Hum Antibodies; 2013; 22(3-4):67-71. PubMed ID: 24961864 [TBL] [Abstract][Full Text] [Related]
4. Preparation of monoclonal antibody against apoptosis-associated antigens of hepatoma cells by subtractive immunization. Yang LJ; Wang WL World J Gastroenterol; 2002 Oct; 8(5):808-14. PubMed ID: 12378620 [TBL] [Abstract][Full Text] [Related]
5. Production of a Mouse Monoclonal Antibody Against Mortalin by Whole Cell Immunization. Rezaei M; Ghaderi A Monoclon Antib Immunodiagn Immunother; 2017 Aug; 36(4):169-175. PubMed ID: 28719245 [TBL] [Abstract][Full Text] [Related]
6. Development of high-affinity monoclonal antibody using CD44 overexpressed cells as a candidate for targeted immunotherapy and diagnosis of acute myeloid leukemia. Amanzadeh A; Heidarnejad F; Abdollahpour-Alitappeh M; Molla-Kazemiha V; Yari S; Hadizadeh-Tasbiti A; Habibi-Anbouhi M; Abolhassani M; Shokrgozar MA Hum Antibodies; 2017; 26(1):7-15. PubMed ID: 28269763 [TBL] [Abstract][Full Text] [Related]
7. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens. Young DA; Prout GR; Lin CW Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas. Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies against human breast tumor-associated antigens: characterization of B21 antigen. Annibali NV; San Martino JA; Baldi A J Natl Cancer Inst; 1994 Feb; 86(3):215-21. PubMed ID: 8283494 [TBL] [Abstract][Full Text] [Related]
10. Human monoclonal antibody reactive to stomach cancer produced by mouse-human hybridoma technique. Yoshikawa K; Ueda R; Obata Y; Utsumi KR; Notake K; Takahashi T Jpn J Cancer Res; 1986 Nov; 77(11):1122-33. PubMed ID: 3098722 [TBL] [Abstract][Full Text] [Related]
11. Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody. Stein R; Basu A; Chen S; Shih LB; Goldenberg DM Int J Cancer; 1993 Dec; 55(6):938-46. PubMed ID: 8253531 [TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of a panel of monoclonal antibodies specific for human fibroblast growth factor receptor 4 (FGFR4). Chen C; Patel S; Corisdeo S; Liu X; Micolochick H; Xue J; Yang Q; Lei Y; Wang B; Soltis D Hybridoma (Larchmt); 2005 Jun; 24(3):152-9. PubMed ID: 15943563 [TBL] [Abstract][Full Text] [Related]
13. Production of murine monoclonal antibodies against cell-surface antigens of human ovarian carcinoma. Bhattacharya M; Chatterjee SK; Gangopadhyay A; Barlow JJ J Surg Oncol; 1985 Dec; 30(4):209-14. PubMed ID: 2417057 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies against antigens on breast cancer cells. Stähli C; Takacs B; Miggiano V; Staehelin T; Carmann H Experientia; 1985 Nov; 41(11):1377-81. PubMed ID: 2415385 [TBL] [Abstract][Full Text] [Related]
15. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer. Yu F; Wang Y; Xiao Y; He Y; Luo C; Duan D; Li C; Xu S; Xiang T Mol Immunol; 2014 May; 59(1):100-9. PubMed ID: 24534066 [TBL] [Abstract][Full Text] [Related]
16. Production and characterization of monoclonal antibodies against human IgG in Balb/c mouse. Majidi J; Baradaran B; Hassan ZM; Mostafaie A Hum Antibodies; 2005; 14(1-2):1-5. PubMed ID: 16424594 [TBL] [Abstract][Full Text] [Related]
17. Production of a monoclonal antibody against a human osteosarcoma xenograft. Chin C; Marks A; Yeger H; Kahn H; Baumal R Hybridoma; 1986; 5(4):339-46. PubMed ID: 3542807 [TBL] [Abstract][Full Text] [Related]
18. [Preparation and identification of monoclonal antibodies against Type M/N and Glycophorin A/B]. Chen Q; Cao H; Zhang HY; Gao XF; Wang F; Li HD Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):556-8. PubMed ID: 17553354 [TBL] [Abstract][Full Text] [Related]
19. Development and characterization of monoclonal antibodies against human CD20 in Balb/c mice. Sepehr KS; Baradaran B; Majidi J; Abdolalizadeh J; Aghebati L; Shahneh FZ Hum Antibodies; 2012; 21(3-4):57-64. PubMed ID: 23549022 [TBL] [Abstract][Full Text] [Related]
20. Development of a new anti-CD123 monoclonal antibody to target the human CD123 antigen as an acute myeloid leukemia cancer stem cell biomarker. Abdollahpour-Alitappeh M; Razavi-Vakhshourpour S; Abolhassani M Biotechnol Appl Biochem; 2018 Nov; 65(6):841-847. PubMed ID: 29972607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]